ATAD2 and ovarian cancer: ATAD2 has also been reported to be targeted by miR-200b-5p in ovarian cancer cells, where miR-200b overexpression suppresses proliferation and promotes the apoptosis of ovarian cancer cells by inhibiting ATAD2 expression [34].